The effect of MCM3AP-AS1 on the progression of CRC cells is obvious, and more studies could target whether MCM3AP-AS1 is associated with drug resistance and angiogenesis in CRC cells. The gene discussed is MCM3AP; the disease is colorectal carcinoma.